Pencegahan Transmisi MRSA di Rumah Sakit

Oleh :

dr. Erizka Rivani, M. Ked. Klin., Sp. MK

Pencegahan transmisi methicillin-resistant Staphylococcus aureus (MRSA) penting dilakukan karena patogen ini bisa menyebabkan infeksi serius bagi pasien di rumah sakit. MRSA merupakan salah satu patogen utama penyebab healthcare-associated infections (HAIs) di rumah sakit.[1]

Penerapan kewaspadaan standar, kewaspadaan berbasis transmisi dalam bentuk kewaspadaan kontak, serta penggunaan antibiotik secara bijak menjadi strategi utama pencegahan transmisi MRSA. Pelaksanaan skrining aktif yang diikuti tindak lanjut berupa strategi dekolonisasi serta isolasi atau kohorting, manajemen tenaga kesehatan dengan kolonisasi, pengendalian lingkungan, surveilans, serta penatagunaan antibiotik juga merupakan tindakan yang direkomendasikan dalam pengendalian MRSA di rumah sakit.[1,2]

Methicillin-Resistant Staphylococcus aureus (MRSA) Sebagai Patogen Penyebab Healthcare-Associated Infections

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Referensi

1. Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 27 Tahun 2017 Pedoman Pencegahan dan Pengendalian Infeksi di Fasilitas Pelayanan Kesehatan. 2017.
2. Coia JE, Wilson JA, Bak A, Marsden GL, Shimonovich M, Loveday HP, Humphreys H, Wigglesworth N, Demirjian A, Brooks J, Butcher L, Price JR, Ritchie L, Newsholme W, Enoch DA, Bostock J, Cann M, Wilson APR. Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2021 Dec;118S:S1-S39. doi: 10.1016/j.jhin.2021.09.022. Epub 2021 Oct 29. Erratum in: J Hosp Infect. 2022 Jul;125:92-93. PMID: 34757174.
3. Salmanov A, Shchehlov D, Svyrydiuk O, Bortnik I, Mamonova M, Korniyenko S, Rud V, Artyomenko V, Gudym M, Maliarchuk R, Bondar T. Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study. J Hosp Infect. 2023 Jan;131:129-138. doi: 10.1016/j.jhin.2022.10.007. Epub 2022 Oct 26. PMID: 36306892.
4. Boswihi SS, Udo EE. Methicillin-resistant Staphylococcus aureus: An update on the epidemiology, treatment options and infection control. Current Medicine Research and Practice, 2018. 8(1), 18-24.
5. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, Holland TL, Fowler VG Jr. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019 Apr;17(4):203-218. doi: 10.1038/s41579-018-0147-4. PMID: 30737488; PMCID: PMC6939889.
6. Larrosa MN, Almirante B. Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals? Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jun 18;39(9):425–8. doi: 10.1016/j.eimc.2021.04.010. Epub ahead of print. PMID: 34154857; PMCID: PMC8213526.
7. National Clinical Effectiveness Committee. Prevention and control methicillin-resistant Staphylococcus aureus (MRSA) national clinical guideline No. 2. 2013
8. Santosaningsih D, et al. Pedoman Pencegahan Dan Pengendalian Methicillin-Resistant Staphylococcus Aureus (MRSA) Di Fasilitas Pelayanan Kesehatan. 2020.
9. Nadimpalli G, O'Hara LM, Pineles L, Lebherz K, Johnson JK, Calfee DP, Miller LG, Morgan DJ, Harris AD. Patient to healthcare personnel transmission of MRSA in the non-intensive care unit setting. Infect Control Hosp Epidemiol. 2020 May;41(5):601-603. doi: 10.1017/ice.2020.10. Epub 2020 Feb 10. PMID: 32036800; PMCID: PMC7200276.
10. Kleyman R, Cupril-Nilson S, Robinson K, Thakore S, Haq F, Chen L, Oyesanmi O, Browning K, Pino J, Mhaskar R. Does the removal of contact precautions for MRSA and VRE infected patients change health care-associated infection rate?: A systematic review and meta-analysis. Am J Infect Control. 2021 Jun;49(6):784-791. doi: 10.1016/j.ajic.2020.11.020. Epub 2020 Dec 1. PMID: 33276000.
11. Haessler S, Martin EM, Scales ME, Kang L, Doll M, Stevens MP, Uslan DZ, Pryor R, Edmond MB, Godbout E, Abbas S, Bearman G. Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: An interrupted time series analysis. Am J Infect Control. 2020 Dec;48(12):1466-1473. doi: 10.1016/j.ajic.2020.06.219. Epub 2020 Jul 4. PMID: 32634537.
12. Cho SY, Chung DR. Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review. Clin Infect Dis. 2017 May 15;64(suppl_2):S82-S90. doi: 10.1093/cid/cix133. PMID: 28475795.
13. Dahesihdewi A, Dwiprahasto I, Wimbarti S, Mulyono B. Reducing Methicillin-Resistant Staphylococcus Aureus (MRSA) cross-infection through hand hygiene improvement in Indonesian intensive tertiary care hospital. Bali Medical Journal, 2018. 7(1), 227-233.
14. Santosaningsih D, Erikawati D, Hakim IA, Santoso S, Hidayat M, Suwenda AH, Puspitasari V, Irhamni I, Kuntaman K, van Arkel ALE, Terlouw LG, Oudenes N, Willemse-Erix D, Snijders SV, Erler NS, Verbrugh HA, Severin JA. Reducing transmission of methicillin-resistant Staphylococcus aureus in a surgical ward of a resource-limited hospital in Indonesia: an intervention study. Infect Prev Pract. 2019 Dec 3;1(3-4):100028. doi: 10.1016/j.infpip.2019.100028. PMID: 34368685; PMCID: PMC8335904.

Diskusi Terbaru